Clinical trials
Completed Phase 1 Carcinoma, Intraductal, Noninfiltrating trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Avelas Biosciences, Inc. | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| NYU Langone Health | 1 |
| Roswell Park Cancer Institute | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
| University of California, San Francisco | 1 |
| University of Chicago | 1 |
| University of Kansas Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Intraductal, Noninfiltrating | 13 |
| Breast Neoplasms | 11 |
| Breast Carcinoma In Situ | 8 |
| Carcinoma, Ductal, Breast | 2 |
| Breast Diseases | 1 |
| Carcinoma, Lobular | 1 |
| Fibroadenoma | 1 |
| Triple Negative Breast Neoplasms | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.